Why the study?
Does an early invasive strategy improve outcomes compared to a selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation and with an elevated cardiac troponin T level?
Does an early invasive strategy improve outcomes compared to a selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation and with an elevated cardiac troponin T level?
In patients with NSTE-ACS and elevated troponin T receiving optimized medical therapy, an early invasive strategy was not shown to be superior to a selectively invasive approach.
Answers are grounded in this paper and cite their sources.
Selective invasive strategy appropriate in NSTE-ACS; extends RCT evidence against routine early intervention.
We could not demonstrate that, given optimized medical therapy, an early invasive strategy was superior to a selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation and with an elevated cardiac troponin T level.
No takes yet. Share an insight, caveat, or question.
Winter et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: